All In Biotech

Free tool

FAERS Monitor: Sodium Phosphates In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018892 or its brand name (Sodium Phosphates In Plastic Container, Sodium Phosphate, Dibasic, Heptahydrate, Sodium Phosphate, Monobasic, Monohydrate). Reports on generic versions are filed under their own applications.

Reports

214

Serious

197

92% of reports

Hospitalization

122

Death reported

51

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • asthenia19
  • diarrhoea19
  • renal failure acute19
  • nausea18
  • constipation16
  • dehydration14
  • fall14
  • pyrexia14
  • vomiting14
  • dizziness13
  • dyspnoea13
  • urinary tract infection13
  • pneumonia12
  • fatigue11
  • nephropathy11

Reports by year received

View as table
YearReports
20042
20052
200622
200719
200821
200928
201023
201114
201216
20131
20151
20163
20174
20187
20191
20203
20216
202210
20235
20249
20259
20268

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,945 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
nephropathySignal11115.965.21,140
renal failure acuteSignal1944.028.7758
dehydrationSignal1410.36.2109
urinary tract infectionSignal137.54.467
constipationSignal167.24.580
astheniaSignal195.03.257
fallSignal144.12.531
pyrexiaSignal144.02.429
pneumoniaSignal123.62.121
vomitingSignal142.91.816
diarrhoeaSignal192.91.922
dizzinessSignal132.61.511
dyspnoeaSignal132.31.38
nauseaSignal182.21.412
fatigue111.40.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.